Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-based Transcriptional Regulation: Technologies, Applications, and Future Directions. | DNA (Basel) | 2025 | 41877893 | PubTator, text mining | PubMed |
| Interplay between hypoxia, RNA methylation, and HPV in head and neck squamous cell carcinomas: drivers of oncogenesis and resistance to therapy. | EXCLI J | 2025 | 41624157 | PubTator, text mining | PubMed |
| Machine learning-based comprehensive analysis of m6A RNA methylation regulators in colorectal cancer: implications for prognosis, immune microenvironment, and immunotherapy response. | Exp Biol Med (Maywood) | 2025 | 41613364 | PubTator, text mining | PubMed |
| Decoding the immunoregulatory functions of ALKBH5 in the tumor microenvironment. | Front Immunol | 2025 | 41562066 | PubTator, text mining | PubMed |
| Targeted RNA base editing for therapeutic: mechanisms and advances. | Pharm Sci Adv | 2025 | 41550651 | PubTator, text mining | PubMed |
| Unveiling novel therapeutic mechanisms of Xinfeng capsule: modulating the ALKBH5-m6A-LINC00968 axis to alleviate oxidative stress-driven NETosis in rheumatoid arthritis. | Front Immunol | 2025 | 41479914 | PubTator, text mining | PubMed |
| TRIM21 promotes K63-linked ubiquitination of ALKBH5 and suppresses cuproptosis via down-regulation of LIAS in esophageal squamous cell carcinoma. | Commun Biol | 2025 | 41413718 | PubTator, text mining | PubMed |
| Early mutational events and clonal dynamics in normal crypts: implications for colorectal tumorigenesis. | Hum Genomics | 2025 | 41392153 | PubTator, text mining | PubMed |
| Co-delivery of camptothecin and SH3RF3-AS1 SiRNA for glioma synergistic therapy. | Cancer Cell Int | 2025 | 41390800 | PubTator, text mining | PubMed |
| Structural Characterization of Protein-Nucleic Acid Complexes: An Overview of the Recent Innovation in the Analytic Methods. | Int J Mol Sci | 2025 | 41373622 | PubTator, text mining | PubMed |
| ALKBH5 gene polymorphisms and Wilms tumour susceptibility in children from East China: a case-control study. | BMJ Paediatr Open | 2025 | 41371711 | PubTator, text mining | PubMed |
| ALKBH5-Mediated ITGB1 m6A Modification in Ovarian Cancer Progression and Immune Evasion. | NPJ Precis Oncol | 2025 | 41366552 | PubTator, text mining | PubMed |
| The Central Role of m6A as Epigenetic Regulator in Metabolic Disorders of Therapeutic Potential and Clinical Implications. | Mol Neurobiol | 2025 | 41339994 | PubTator, text mining | PubMed |
| DAZAP1 promotes cancer progression and chemotherapy resistance by stabilizing PIN1 protein in gastric cancer. | Cell Biol Toxicol | 2025 | 41331184 | PubTator, text mining | PubMed |
| ALKBH5 Regulates Apoptosis of Rheumatoid Arthritis Fibroblast-like Synoviocytes by Modulating miR-181b-5p Maturation via m6A Demethylation. | J Musculoskelet Neuronal Interact | 2025 | 41324215 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated transfer of MIR22HG inhibits the colonization of enteric neural crest cells in the colon by decreasing MPP3 expression. | Commun Biol | 2025 | 41286351 | PubTator, text mining | PubMed |
| Directed evolution of an m6A eraser for site-selective epitranscriptome editing. | Res Sq | 2025 | 41282238 | PubTator, text mining | PubMed |
| ALKBH5 demethylation modification of SE-lncRNA ZMIZ1-AS1 promotes FGFR1-mediated proliferation and invasive metastasis in osteosarcoma. | Cell Mol Life Sci | 2025 | 41275058 | PubTator, text mining | PubMed |
| Structural Control of RNA Demethylation: G-Quadruplex Proximity Suppresses ALKBH5 Activity. | Chemistry | 2025 | 41273004 | PubTator, text mining | PubMed |
| The impact of miR-221-3p modification by the m6A demethylase ALKBH5 on the inflammatory response in spinal tuberculosis and its diagnostic significance. | J Orthop Surg Res | 2025 | 41272849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=10